Lawrence Lapointe
Genetics & Molecular Biology
Clinical Genomics
Australia
Biography
Dr. Lawrence LaPointe is a co-founder and CEO of Clinical Genomics. Prior to launching the Company, Dr. LaPointe co-founded Enterix Inc. in 1997 and served as a member of its executive team until that Company was sold in 2006. As General Manager from start-up until 2000, he introduced the world's first dedicated colorectal cancer screening service using a novel kit. Dr. LaPointe has also served as Lab Manager of the Centre for Molecular Imaging Research at Massachusetts General Hospital (Harvard Medical School). Dr. LaPointe holds a Ph.D. in Bioinformatics (Flinders University, Australia) and a B.Sc. in Biological Sciences (Florida State University, USA). He holds multiple patents and has authored numerous scientific articles, conference presentations and invited talks.
Research Interest
Molecular Imaging and Biological Science
